HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis.

Abstract
CD8(+) T cells recognizing minor histocompatibility antigens (MiHA) on solid tumor cells may mediate effective graft-versus-tumor (GVT) reactivity after allogeneic stem cell transplantation (SCT). Previously, we identified LRH-1 as a hematopoietic-restricted MiHA encoded by the P2X5 gene. Here, we report that LRH-1 is aberrantly expressed on solid tumor cells. P2X5 mRNA expression is demonstrated in a significant portion of solid tumor cell lines, including renal cell carcinoma (RCC), melanoma, colorectal carcinoma, brain cancer and breast cancer. Importantly, P2X5 gene expression was also detected in a subset of primary solid tumor specimens derived from RCC, brain cancer and breast cancer patients. Furthermore, P2X5 expressing solid tumor cells can be effectively targeted by LRH-1-specific cytotoxic T lymphocytes under inflammatory conditions. The expression of HLA-B7 and CD54 on tumor cells increases upon cytokine stimulation resulting in improved T cell activation as observed by higher levels of degranulation and enhanced tumor cell lysis. Overall, hematopoietic-restricted MiHA LRH-1 is aberrantly expressed on solid tumor cells and may be used as target in GVT-specific immunotherapy after SCT.
AuthorsIngrid M Overes, T Henriëtte Levenga, Johanna C M Vos, Agnes van Horssen-Zoetbrood, Robbert van der Voort, Pieter H De Mulder, Theo M de Witte, Harry Dolstra
JournalCancer immunology, immunotherapy : CII (Cancer Immunol Immunother) Vol. 58 Issue 3 Pg. 429-39 (Mar 2009) ISSN: 1432-0851 [Electronic] Germany
PMID18719914 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • Minor Histocompatibility Antigens
  • P2RX5 protein, human
  • RNA, Messenger
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2X5
  • Transcription Factors
  • Intercellular Adhesion Molecule-1
Topics
  • CD8-Positive T-Lymphocytes (immunology)
  • DNA-Binding Proteins (metabolism, physiology)
  • Genotype
  • Hematopoietic System (metabolism)
  • Humans
  • Immunotherapy (methods)
  • Intercellular Adhesion Molecule-1 (biosynthesis)
  • Microscopy, Fluorescence (methods)
  • Minor Histocompatibility Antigens (metabolism)
  • Neoplasms (immunology, metabolism)
  • RNA, Messenger (metabolism)
  • Receptors, Purinergic P2 (metabolism)
  • Receptors, Purinergic P2X5
  • Stem Cell Transplantation
  • T-Lymphocytes (metabolism)
  • Transcription Factors (metabolism, physiology)
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: